Kelly A. Plummer, Ph.D. focuses her practice on pharmaceutical and biotechnology patent matters with an emphasis on patent prosecution and pre-litigation counseling. Kelly assists clients with intellectual property due diligence related to acquisitions and venture capital financing. She advises clients regarding patentability, infringement, patent validity, and freedom-to-operate. Kelly also has experience with biosimilar litigation and post-grant proceedings at the US Patent and Trademark Office.
Kelly represents clients in patent prosecution matters before the US Patent and Trademark Office and internationally under the Patent Cooperation Treaty, as well as in managing their worldwide patent portfolios. Her practice encompasses a broad range of pharmaceutical and biopharmaceutical subject matter, including antibody therapeutics, drug delivery, formulations, manufacturing and purification of biologics, small molecule pharmaceuticals, and therapeutic methods.
Kelly received her Ph.D. from Harvard University in the department of chemistry and chemical biology. Her doctoral work focused on developing systems for modulating the affinity and specificity of small molecules for therapeutic RNA targets.
Before joining Morgan Lewis, Kelly was an associate at another international law firm and a Chicago-based intellectual property boutique. Before that, she worked as a scientific researcher at a large biotechnology company.
Represented a biosimilar applicant in pre-suit exchange of information under the Biologics Price Competition and Innovation Act (BPCIA)
Provided freedom-to-operate analyses for antibody products and related formulations, methods of treatment, and manufacturing and purification methods
Advised a biosimilar manufacturer regarding strategic enforcement of its patent portfolio
Prepared expert declarations supporting petitions for inter partes review for an international biotechnology company
Conducted due diligence related to acquisition of a branded small molecule antibiotic
Drafted and prosecuted patent applications related to surgical sealants, adhesion prevention, and tissue repair for a major healthcare company
Managed the international patent portfolio for a privately-held diagnostics company
Chicago-Kent College of Law, 2012, J.D., cum laude
Harvard University, 2005, Ph.D., Chemistry and Chemical Biology
Harvard University, 2002, A.M., Chemistry and Chemical Biology
University of Minnesota, 1999, B.S., Chemistry, with High Distinction
University of Minnesota, 1999, B.S., Mathematics, with High Distinction
US Patent and Trademark Office
Awards and Affiliations
Recognized, Illinois Rising Star, Illinois Super Lawyers Magazine (2017-2020)